Work

389 POSTER Phase I study of the ribosome inactivating protein prodrug TST10088 (TST88) in patients with advanced solid tumors

Year: 2008

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(08)72323-1

Authors: I. Duran, L.L. Siu, C. Kollmannsberger, L. Gontovnick, S. Leong, L. Wang, C. Braun, T. Borgford, S.G. Eckhardt, L. Gore

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1976607142

Cites:

Cited by:

Related to: 10